Welcome to our dedicated page for Axon Enterprise SEC filings (Ticker: AXON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Axon Enterprise's SEC filings reveal how its business model splits between one-time hardware sales and recurring subscription revenue from Evidence.com cloud services. The company's 10-K annual reports break down revenue by product category, showing the growing contribution of software subscriptions compared to traditional conducted electrical weapon sales. These segment disclosures help you understand whether Axon operates primarily as a hardware manufacturer or an increasingly software-focused company.
Quarterly 10-Q filings track the subscription backlog, which represents contracted future revenue from multi-year evidence management agreements with law enforcement agencies. This metric signals the stability of Axon's recurring revenue base and the stickiness of its platform once agencies adopt the integrated ecosystem. The filings also disclose research and development spending focused on artificial intelligence applications for automated video processing and evidence categorization.
Form 4 insider transaction filings show when executives and board members buy or sell AXON shares, providing insight into insider confidence during periods of contract wins, product launches, or regulatory developments affecting the law enforcement technology market. Material events captured in 8-K filings include major agency contract awards, acquisition announcements, and strategic partnerships that expand Axon's addressable market beyond traditional policing into corrections, corporate security, and international law enforcement.
Our AI assistance highlights revenue segment breakdowns instantly, extracts subscription metrics from dense financial footnotes, and tracks how deferred revenue and contract liabilities evolve quarter-over-quarter as agencies sign and renew agreements.
Axon Enterprise, Inc. filed a Form 144 notifying of a proposed sale of 15,919 shares of common stock through Merrill Lynch on 08/15/2025 on Nasdaq with an aggregate market value of $11,879,088.00. The shares were acquired as an equity award from the issuer on 08/13/2025 and payment is indicated as cash. The filer also reported four prior sales during the past three months totaling 15,810 shares on 05/21/2025, 06/17/2025, 08/07/2025 and 08/12/2025 with combined gross proceeds of $12,110,841.00. The filing includes the required attestation that the seller is not aware of undisclosed material adverse information.
Patrick W. Smith, Axon CEO and director, reported multiple open-market sales of common stock executed pursuant to a Rule 10b5-1 trading plan adopted May 12, 2025. The Form 4 lists 16 separate sales on 08/11/2025 totaling 10,000 shares executed in multiple trades with reported weighted-average prices by tranche. Reported per-share execution ranges span approximately $821.50 to $839.11. After the reported transactions the filing shows the reporting person beneficially owned 3,053,982 shares of Axon.
The filing discloses the trades were made under a written 10b5-1 plan and provides weighted-average sale prices for each block; the submission is a routine insider disclosure of securities dispositions and the specific trade execution details are available upon request to the SEC staff, issuer or security holders per the filer’s statement.
Joshua Isner, an officer (President) of Axon Enterprise, reported multiple sales of the company’s common stock executed on 08/07/2025. The Form 4 lists five sale tranches that together total 2,500 shares sold, with reported weighted-average sale prices of $867.4875, $868.50, $869.7092, $871.2756 and $872.1513, and disclosed execution price ranges approximately $867.15 to $872.34.
After these transactions the reporting person is shown as directly owning 266,235 shares. No derivative securities were reported and the filer offers to provide full trade-level details to the SEC or security holders upon request.
Caitlin E. Kalinowski, identified as a director of Axon Enterprise (AXON), reported two separate sales of common stock on 08/07/2025 totaling 580 shares.
The filing shows a sale of 476 shares at a weighted-average price of $870.7414 and a sale of 104 shares at a weighted-average price of $872.0066. The two report lines list beneficial ownership amounts of 4,799 and 4,695 shares following the respective transactions. The Form 4 was executed through an attorney-in-fact and discloses the transaction details and weighted-average prices without additional commentary.
In this Form 144 notice for Axon Enterprise, Inc., the filer reports an intended sale of 10,000 shares of common stock through UBS Financial Services on Nasdaq with an aggregate market value of $8,428,900 and an approximate sale date of 08/11/2025. The shares were acquired on 11/15/2021 via an option exercise and paid in cash. The filing lists 78,504,440 shares outstanding, so the proposed sale represents about 0.0127% of outstanding shares.
The form shows no securities sold by the filer in the past three months and includes the standard Rule 144 representation that the filer does not possess undisclosed material adverse information. A broker is named and the transaction mechanics (option exercise, cash payment) are disclosed.
FAQ
What is the current stock price of Axon Enterprise (AXON)?
What is the market cap of Axon Enterprise (AXON)?
